Skip to main content
Clinical Trials/NCT06090253
NCT06090253
Recruiting
N/A

A Hybrid Effectiveness-implementation Evaluation on Programs Promoting Healthy Aging With Sport Exercise (PHASE Program)

The University of Hong Kong1 site in 1 country1,940 target enrollmentSeptember 1, 2023
ConditionsAgeing Well

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ageing Well
Sponsor
The University of Hong Kong
Enrollment
1940
Locations
1
Primary Endpoint
Mobility limitation score
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

The goal of this clinical trial is to provide scientific evaluation on the effects of Promoting Healthy Aging with Sport Exercise (PHASE) Programs on the functional capacity of older. Based on the participants' mental well-being and physical health status, they will be provided with several tailored exercise intervention, including 1) football training; 2) gero-technology enhanced multi-component exercise; 3) slow sports and exercise; 4) walking exercise; 5) home-based exercise. A control group is also recruited and provided with no exercise intervention.

Detailed Description

This clinical trial is aimed to match a range of sport exercise to older adults who are in the different phase of transition along the continuum of intrinsic capacity, and to explore effective measures to promote healthy aging. The effectiveness of the tailored interventions will be tested among the six study arms of older adults with different intrinsic capacities, with five intervention arms and one control. Exercise intensity will be measured for each participant. The outcomes are overall health status, physical function, psychological function, and cognitive function. The outcomes are measured at baseline (pre-intervention), 3 months (post-intervention), and 6 months (post-intervention) to explore the program benefits.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
December 31, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age above 60 years

Exclusion Criteria

  • Any contraindication to exercise training

Outcomes

Primary Outcomes

Mobility limitation score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention.

Measured by Short Physical Performance Battery (range 0-12), higher score better physical performance

Sarcopenia risk score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Measured by Sarcopenia(SARC) questionnaire and calf circumference in unit of cm (range0-20), higher score higher risk of sarcopenia

Functional mobility score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Score measured by Life Space Assessment questionnaire (range: 0-120), higher score better performance

Hand grip strength

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Hand grip strength measured by hand-held dynamometer in unit of KG

Cognitive function score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Measured by Montreal Cognitive Assessment (range 0-30), A score of 26 or over is considered to be normal.

Health status self-rated score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Measure by EQ05D-5L (range -0.59-1.0), higher score better quality of life

Activity level

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Measured by International Physical Activity Questionnaire.

Loneliness score

Time Frame: Changes from baseline to 3 month and 6 month post-intervention

Measured by UCLA Loneliness Scale questionnaire (range20-80), higher score greater loneliness

Study Sites (1)

Loading locations...

Similar Trials